CDC Financial, Inc.

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 2077836 CHICAGO, IL

Position in ZNTL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$862,145

+$198,142 QoQ

Shares Held

177,762

-37.4% QoQ

Ownership

0.248%

of shares outstanding

% of Portfolio

0.67%

of 13F equity value

Holder Rank

#40

of 114 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

CDC Financial, Inc. holds $14,144,132 across 3 Biotechnology names. ZNTL ranks #2 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	140,130	$13,277,317
2	ZNTL	Zentalis Pharmaceuticals, Inc. This page	177,762	$862,145
3	CCCC	C4 Therapeutics, Inc.	1,000	$4,670

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$862,145	177,762	-37.4%	Shares	Defined	2026-08-14
2026-03-31	$664,003	283,762	—	Shares	Defined	2026-05-15
No filing history on record for this holder in this stock.